How Understanding Breast Cancer Heterogeneity Could Point to New Drug Targets – Safe Cell & Gene

Read article - Cites comments by Diwakar Pattabiraman, assistant professor of molecular and systems biology, in an article about a study he co-authored that uncovered clues in how heterogeneity arises in breast cancer and a potential method for making breast tumors more responsive to therapy.